Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.

Hu-Lieskovan, Siwen

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 08 2019 - 5061-5068 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-18-4275 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents, Immunological--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Immunohistochemistry
Lung Neoplasms--drug therapy
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Treatment Outcome
Exome Sequencing